Schedule 13D ownership disclosure
TETRAPHASE PHARMA
Security class unavailable · CUSIP: 88165N204
Event date: 2020-06-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-20-004380
- Form type
- SC 13D
- Filer
- ARMISTICE CAPITAL, LLC
- CIK
- CIK 1601086
- Filed
- Jun 30, 2020
- Reporting period
- Jun 24, 2020
- Description
- Schedule 13D beneficial ownership